Related Experiment Video
Updated: Mar 16, 2026

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
Published on: September 1, 2010
L-MYC Expression Maintains Self-Renewal and Prolongs Multipotency of Primary Human Neural Stem Cells
Zhongqi Li1, Diana Oganesyan1, Rachael Mooney1
1Department of Developmental and Stem Cell Biology, City of Hope National Medical Center and Beckman Research Institute of City of Hope, 1500 East Duarte Road, Duarte, CA 91010, USA.
Abstract:
Pre-clinical studies indicate that neural stem cells (NSCs) can limit or reverse CNS damage through direct cell replacement, promotion of regeneration, or delivery of therapeutic agents. Immortalized NSC lines are in growing demand due to the inherent limitations of adult patient-derived NSCs, including availability, expandability, potential for genetic modifications, and costs. Here, we describe the generation and characterization of a new human fetal NSC line, immortalized by transduction with L-MYC (LM-NSC008) that in vitro displays both self-renewal and multipotent differentiation into neurons, oligodendrocytes, and astrocytes. These LM-NSC008 cells were non-tumorigenic in vivo, and migrated to orthotopic glioma xenografts in immunodeficient mice. When administered intranasally, LM-NSC008 distributed specifically to sites of traumatic brain injury (TBI). These data support the therapeutic development of immortalized LM-NSC008 cells for allogeneic use in TBI and other CNS diseases.
Insights
A new human neural stem cell (NSC) line, LM-NSC008, shows promise for treating central nervous system (CNS) damage. These cells are non-tumorigenic and migrate to injury sites, supporting their therapeutic potential in traumatic brain injury (TBI).
Area of Science:
- Neuroscience
- Stem Cell Biology
- Regenerative Medicine
Background:
- Neural stem cells (NSCs) offer therapeutic potential for central nervous system (CNS) damage.
- Limitations of patient-derived NSCs necessitate the development of immortalized cell lines.
- Immortalized NSCs are crucial for advancing cell replacement and regenerative therapies.
Purpose of the Study:
- To generate and characterize a novel immortalized human fetal neural stem cell line (LM-NSC008).
- To evaluate the therapeutic potential of LM-NSC008 cells in preclinical models of CNS injury.
Main Methods:
- Generation of immortalized human fetal neural stem cells (NSCs) via L-MYC transduction.
- In vitro characterization of self-renewal and multipotent differentiation capabilities.
- In vivo assessment of non-tumorigenicity, migration to glioma xenografts, and homing to traumatic brain injury (TBI) sites.
Main Results:
- LM-NSC008 cells demonstrated robust self-renewal and differentiated into neurons, oligodendrocytes, and astrocytes in vitro.
- These cells were non-tumorigenic in vivo and migrated effectively to orthotopic glioma xenografts.
- Intranasal administration showed specific distribution of LM-NSC008 cells to traumatic brain injury (TBI) sites.
Conclusions:
- The immortalized LM-NSC008 cell line possesses key characteristics for therapeutic applications in CNS disorders.
- LM-NSC008 cells show promise for allogeneic transplantation in traumatic brain injury (TBI) and other neurological conditions.
- This study supports the further development of LM-NSC008 for clinical use in regenerative medicine.
More Related Videos
Related Concept Videos
Induced Pluripotent Stem Cells
Somatic...
Multipotency of Hematopoietic Stem Cells
Maintenance of the ES Cell State
Somatic to iPS Cell Reprogramming
Methods of Nuclear Reprogramming
Abnormal Proliferation

